Last reviewed · How we verify

Norepinephrine (10 µg boluses)

Hopital Charles Nicolle · FDA-approved active Small molecule

Norepinephrine is a catecholamine that binds to alpha and beta adrenergic receptors to increase heart rate, cardiac contractility, and peripheral vasoconstriction, thereby raising blood pressure and improving tissue perfusion.

Norepinephrine is a catecholamine that binds to alpha and beta adrenergic receptors to increase heart rate, cardiac contractility, and peripheral vasoconstriction, thereby raising blood pressure and improving tissue perfusion. Used for Acute hypotension in critical care settings, Cardiogenic shock, Septic shock (adjunctive therapy).

At a glance

Generic nameNorepinephrine (10 µg boluses)
SponsorHopital Charles Nicolle
Drug classCatecholamine; sympathomimetic amine
TargetAlpha-1 adrenergic receptor; Beta-1 adrenergic receptor
ModalitySmall molecule
Therapeutic areaCardiovascular; Critical Care
PhaseFDA-approved

Mechanism of action

Norepinephrine acts as both a neurotransmitter and sympathomimetic agent, activating alpha-1 adrenergic receptors (causing vasoconstriction) and beta-1 adrenergic receptors (increasing heart rate and contractility). In bolus form, it produces rapid but short-lived hemodynamic effects, making it useful for acute hypotensive episodes. The drug increases systemic vascular resistance and cardiac output, restoring perfusion pressure to vital organs.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results